Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C4HE | ISIN: US29415J1060 | Ticker-Symbol: 5HJ
Tradegate
02.09.25 | 15:25
0,715 Euro
+2,14 % +0,015
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ENVVENO MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
ENVVENO MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,6800,71008:36
0,6800,71008:34

Aktuelle News zur ENVVENO MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.08.NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve13
20.08.FDA denies PMA submission for enVVeno Medical's VenoValve10
ENVVENO MEDICAL Aktie jetzt für 0€ handeln
20.08.XFRA 5HJ: WIEDERAUFNAHME/RESUMPTION236FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
20.08.enVVeno Medical stock plummets after FDA rejects VenoValve approval14
20.08.FDA verweigert Zulassung für VenoValve: Aktie von enVVeno Medical stürzt um 70 % ab12
20.08.Rückschlag für enVVeno Medical: FDA verweigert Zulassung für Venenklappe VenoValve14
20.08.FDA rejects enVVeno Medical's VenoValve for chronic venous insufficiency4
20.08.enVVeno Medical Corp - 8-K, Current Report6
20.08.XFRA 5HJ: AUSSETZUNG/SUSPENSION349DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILENVVENO MEDICAL...
► Artikel lesen
20.08.enVVeno Medical Corporation: enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve485IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease...
► Artikel lesen
15.08.enVVeno Medical Corporation: enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech261- Live webcast on Thursday, August 21stat 2:00 PM ET IRVINE, CA / ACCESS Newswire / August 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards...
► Artikel lesen
06.08.enVVeno Medical's VenoValve shows cost-effectiveness for CVI treatment2
06.08.enVVeno Medical Corporation: Health Economic Study Shows That enVVeno Medical's VenoValve Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency272Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatmentsThe VenoValve could...
► Artikel lesen
04.08.enVVeno Medical Corporation: enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company206- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency- FDA decision expected...
► Artikel lesen
01.08.enVVeno Medical reports Q2 results1
01.08.enVVeno Medical Corporation: enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update487- Cash burn of $3.8 million in Q2 remains in line with projected quarterly range- Cash and investments are sufficient to fund operations through Q3'2026 at current cash burn rate- Commercial readiness...
► Artikel lesen
31.07.enVVeno Medical Corp - 10-Q, Quarterly Report2
22.07.enVVeno Medical Corporation: enVVeno Medical Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference216- Video webcast now available on-demand IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care...
► Artikel lesen
06.06.enVVeno Medical Corporation: Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery 2025 Vascular Annual Meeting319Interim two-year follow-up data from 42 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit at 24 months compared to baseline83% of subjects maintained...
► Artikel lesen
20.05.enVVeno Medical Corp - 8-K, Current Report1
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1